Results 11 to 20 of about 35,468 (143)

HPV Vaccine Recommendations [PDF]

Pediatrics, 2012
This Policy Statement was retired June 2015. On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males.
Michael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary P. Glode, Mary Anne Jackson, Harry L. Keyserling, Yvonne A. Maldonado, Dennis L. Murray, Walter A. Orenstein, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis   +12 more
openaire   +2 more sources

Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium

BMC Public Health, 2016
Background Although female sex workers (FSWs) are a well-known high-risk group for Human Papillomavirus (HPV) infections, few tailored intervention programmes for HPV have been established worldwide. The lack of reliable data on the prevalence of HPV and
Alex Vorsters, Tine Cornelissen, Elke Leuridan, Johannes Bogers, Davy Vanden Broeck, Ina Benoy, Herman Goossens, Niel Hens, Pierre Van Damme   +8 more
doaj   +1 more source

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. [PDF]

PLoS Medicine, 2010
BACKGROUND: Information on factors that influence parental decisions for actual human papillomavirus (HPV) vaccine receipt in publicly funded, school-based HPV vaccine programs for girls is limited.
Gina Ogilvie, Maureen Anderson, Fawziah Marra, Shelly McNeil, Karen Pielak, Meena Dawar, Marilyn McIvor, Thomas Ehlen, Simon Dobson, Deborah Money, David M Patrick, Monika Naus   +11 more
doaj   +1 more source

Psychosocial correlates of HPV vaccine acceptability in college males: A cross-sectional exploratory study

Papillomavirus Research, 2017
Background: Most college males are not immunized against the human papillomavirus (HPV) and are at high risk of HPV infection. Most research of correlates of HPV vaccine acceptability in college males has assessed vaccine acceptability as a binary ...
Ovidiu Tatar, Samara Perez, Anila Naz, Gilla K. Shapiro, Zeev Rosberger   +4 more
doaj   +1 more source

HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US

Papillomavirus Research, 2016
Background: Although HPV vaccination has been recommended for use in girls and young women since 2007, HPV vaccine uptake is low in the US. Methods: We conducted a retrospective cohort study using the 2008–2011 MarketScan data to examine HPV vaccine ...
Guodong Liu, Lan Kong, Ping Du
doaj   +1 more source

Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia

Human Vaccines & Immunotherapeutics, 2021
Human papillomavirus (HPV), the most common sexually transmitted infection worldwide, is responsible for a variety of cancers. HPV vaccines can help prevent this infection and its potentially devastating carcinogenic outcomes.
Nada J. Farsi, Asala H. Baharoon, Afnan E. Jiffri, Hani Z. Marzouki, Mazin A. Merdad, Leena A. Merdad   +5 more
doaj   +1 more source

Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda.

PLoS ONE, 2022
IntroductionWHO recommends vaccination against HPV for girls before sexual debut. Uganda started HPV vaccination in 2008 as pilot programs in 2 districts, followed by national roll out in 2015.
Lydia Patrick, Sabrina Bakeera-Kitaka, Joseph Rujumba, Oliver Ombeva Malande   +3 more
doaj   +1 more source

Factors associated with HPV vaccine acceptability and hesitancy among Black mothers with young daughters in the United States

Frontiers in Public Health, 2023
IntroductionCompared to other-race peers, Black women are disproportionately impacted by human papillomavirus [HPV] infection, related health outcomes, and cervical cancer mortality as a result of suboptimal HPV vaccine uptake during adolescence.
Aaliyah Gray, Aaliyah Gray, Celia B. Fisher, Celia B. Fisher   +3 more
doaj   +1 more source

Therapeutic HPV vaccines [PDF]

Best Practice & Research Clinical Obstetrics & Gynaecology, 2018
High-risk human papillomavirus (HPV) infection is known to be a necessary factor for cervical and anogenital malignancies. Cervical cancers account for over a quarter of a million deaths annually. Despite the availability of prophylactic vaccines, HPV infections remain extremely common worldwide.
Hancock, G, Hellner, K, Dorrell, L
openaire   +3 more sources

Updates on HPV Vaccination

Diagnostics, 2023
Cervical cancer still poses a significant global challenge. Developed countries have mitigated this challenge by the introduction of structured screening programmes and, more recently, the HPV vaccine. Countries that have successfully introduced national HPV vaccination programmes are on course for cervical cancer elimination in a few decades.
Ojone Illah, Adeola Olaitan
openaire   +3 more sources